Search research articles
Contact Us
Filters
Showing results (71-80 of 86) with videos related to
Page
of 9
Sort By:
International Braz J Urol : Official Journal of the Brazilian Society of Urology
|
March 20, 2025
Systematic Review and Clinical Outcomes of new Robotic Systems in Urology
Iulia Andras, Federico Piramide, Carlo Andrea Bravi, et al.
World Journal of Urology
|
November 29, 2019
Artificial intelligence and robotics: a combination that is changing the operating room
Iulia Andras, Elio Mazzone, Fijs W B van Leeuwen, et al.
European Urology Focus
|
November 8, 2017
Robot-assisted Partial Nephrectomy: 5-yr Oncological Outcomes at a Single European Tertiary Cancer Center
Mihai Dorin Vartolomei, Deliu Victor Matei, Giuseppe Renne, et al.
Urologia Internationalis
|
July 6, 2018
High-Grade T1 on Re-Transurethral Resection after Initial High-Grade T1 Confers Worse Oncological Outcomes: Results of a Multi-Institutional Study
Matteo Ferro, Mihai Dorin Vartolomei, Francesco Cantiello, et al.
Clinical Genitourinary Cancer
|
August 6, 2018
Validation of Neutrophil-to-lymphocyte Ratio in a Multi-institutional Cohort of Patients With T1G3 Non-muscle-invasive Bladder Cancer
Mihai Dorin Vartolomei, Matteo Ferro, Francesco Cantiello, et al.
Translational Andrology and Urology
|
March 15, 2021
Systemic combining inflammatory score (SCIS): a new score for prediction of oncologic outcomes in patients with high-risk non-muscle-invasive urothelial bladder cancer
Matteo Ferro, Marina Di Mauro, Sebastiano Cimino, et al.
European Urology Oncology
|
June 4, 2019
Systemic Inflammatory Markers and Oncologic Outcomes in Patients with High-risk Non-muscle-invasive Urothelial Bladder Cancer
Francesco Cantiello, Giorgio I Russo, Mihai Dorin Vartolomei, et al.
Urologic Oncology
|
March 17, 2020
Type 2 diabetes mellitus predicts worse outcomes in patients with high-grade T1 bladder cancer receiving bacillus Calmette-Guérin after transurethral resection of the bladder tumor
Matteo Ferro, Martha Orsolya Katalin, Carlo Buonerba, et al.
Diagnostics (Basel, Switzerland)
|
March 25, 2022
Modified Glasgow Prognostic Score as a Predictor of Recurrence in Patients with High Grade Non-Muscle Invasive Bladder Cancer Undergoing Intravesical Bacillus Calmette-Guerin Immunotherapy
Matteo Ferro, Octavian Sabin Tătaru, Gennaro Musi, et al.
World Journal of Urology
|
July 12, 2018
An increased body mass index is associated with a worse prognosis in patients administered BCG immunotherapy for T1 bladder cancer
Matteo Ferro, Mihai Dorin Vartolomei, Giorgio Ivan Russo, et al.
Page
of 9
Search research articles
Search
Showing results (71-80 of 86) with videos related to
Sort By:
Page
of 9
International Braz J Urol : Official Journal of the Brazilian Society of Urology
|
March 20, 2025
Systematic Review and Clinical Outcomes of new Robotic Systems in Urology
Iulia Andras, Federico Piramide, Carlo Andrea Bravi, et al.
World Journal of Urology
|
November 29, 2019
Artificial intelligence and robotics: a combination that is changing the operating room
Iulia Andras, Elio Mazzone, Fijs W B van Leeuwen, et al.
European Urology Focus
|
November 8, 2017
Robot-assisted Partial Nephrectomy: 5-yr Oncological Outcomes at a Single European Tertiary Cancer Center
Mihai Dorin Vartolomei, Deliu Victor Matei, Giuseppe Renne, et al.
Urologia Internationalis
|
July 6, 2018
High-Grade T1 on Re-Transurethral Resection after Initial High-Grade T1 Confers Worse Oncological Outcomes: Results of a Multi-Institutional Study
Matteo Ferro, Mihai Dorin Vartolomei, Francesco Cantiello, et al.
Clinical Genitourinary Cancer
|
August 6, 2018
Validation of Neutrophil-to-lymphocyte Ratio in a Multi-institutional Cohort of Patients With T1G3 Non-muscle-invasive Bladder Cancer
Mihai Dorin Vartolomei, Matteo Ferro, Francesco Cantiello, et al.
Translational Andrology and Urology
|
March 15, 2021
Systemic combining inflammatory score (SCIS): a new score for prediction of oncologic outcomes in patients with high-risk non-muscle-invasive urothelial bladder cancer
Matteo Ferro, Marina Di Mauro, Sebastiano Cimino, et al.
European Urology Oncology
|
June 4, 2019
Systemic Inflammatory Markers and Oncologic Outcomes in Patients with High-risk Non-muscle-invasive Urothelial Bladder Cancer
Francesco Cantiello, Giorgio I Russo, Mihai Dorin Vartolomei, et al.
Urologic Oncology
|
March 17, 2020
Type 2 diabetes mellitus predicts worse outcomes in patients with high-grade T1 bladder cancer receiving bacillus Calmette-Guérin after transurethral resection of the bladder tumor
Matteo Ferro, Martha Orsolya Katalin, Carlo Buonerba, et al.
Diagnostics (Basel, Switzerland)
|
March 25, 2022
Modified Glasgow Prognostic Score as a Predictor of Recurrence in Patients with High Grade Non-Muscle Invasive Bladder Cancer Undergoing Intravesical Bacillus Calmette-Guerin Immunotherapy
Matteo Ferro, Octavian Sabin Tătaru, Gennaro Musi, et al.
World Journal of Urology
|
July 12, 2018
An increased body mass index is associated with a worse prognosis in patients administered BCG immunotherapy for T1 bladder cancer
Matteo Ferro, Mihai Dorin Vartolomei, Giorgio Ivan Russo, et al.
Page
of 9